115 related articles for article (PubMed ID: 37085423)
1. Corrigendum to "Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks" [Neurochem. Int. 138 (2020) 104777].
Wahdan SA; El-Derany MO; Abdel-Maged AE; Azab SS
Neurochem Int; 2023 Jun; 166():105525. PubMed ID: 37085423
[No Abstract] [Full Text] [Related]
2. Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks.
Wahdan SA; El-Derany MO; Abdel-Maged AE; Azab SS
Neurochem Int; 2020 Sep; 138():104777. PubMed ID: 32479984
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "Early life neuroimmune challenge protects the brain after sepsis in adult rats" [Neurochem. Int. 2020 May 135 104712].
Florentino D; Della Giustina A; de Souza Goldim MP; Danielski LG; de Oliveira Junior AN; Joaquim L; Bonfante S; Biehl E; da Rosa N; Fernandes D; Gava FF; Michels M; Fortunato JJ; Réus GZ; Valvassori SS; Quevedo J; Dal-Pizzol F; Barichello T; Petronilho F
Neurochem Int; 2020 Jul; 137():104732. PubMed ID: 32276800
[No Abstract] [Full Text] [Related]
4. Bone marrow mesenchymal stem cells and their derived exosomes resolve doxorubicin-induced chemobrain: critical role of their miRNA cargo.
El-Derany MO; Noureldein MH
Stem Cell Res Ther; 2021 Jun; 12(1):322. PubMed ID: 34090498
[TBL] [Abstract][Full Text] [Related]
5. Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain.
Park HS; Kim CJ; Kwak HB; No MH; Heo JW; Kim TW
Neuropharmacology; 2018 May; 133():451-461. PubMed ID: 29477301
[TBL] [Abstract][Full Text] [Related]
6. The diuretic amiloride attenuates doxorubicin-induced chemobrain in rats: Behavioral and mechanistic study.
Ali AE; Elsherbiny DM; Azab SS; El-Demerdash E
Neurotoxicology; 2022 Jan; 88():1-13. PubMed ID: 34656704
[TBL] [Abstract][Full Text] [Related]
7. Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's Disease.
Grossi V; Lerer T; Griffiths A; LeLeiko N; Cabrera J; Otley A; Rick J; Mack D; Bousvaros A; Rosh J; Grossman A; Saeed S; Kay M; Boyle B; Oliva-Hemker M; Keljo D; Pfefferkorn M; Faubion W; Kappelman MD; Sudel B; Markowitz J; Hyams JS
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1748-56. PubMed ID: 25911120
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum to "FMRP-absence-induced up-regulation of hypothalamic MAP1B expression decreases AgRP level linking with reduces in food intake and body weight" [Neurochem. Int. 140 (2020) 104847].
Long JY; Jiang W; Xia HB; Fu JY; Lu P; Hu F; Feng WC; Sun WW; Gao MM; Yi YH; Long YS
Neurochem Int; 2021 Mar; 144():104903. PubMed ID: 33223044
[No Abstract] [Full Text] [Related]
9. Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats.
Tong Y; Wang K; Sheng S; Cui J
Biosci Biotechnol Biochem; 2020 Jun; 84(6):1201-1210. PubMed ID: 31992173
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum to "Impairment of mitochondrial function by particulate matter: Implications for the brain" [Neurochem. Int. 135 (May 2020) 104694].
Chew S; Kolosowska N; Saveleva L; Malm T; Kanninen KM
Neurochem Int; 2020 Oct; 139():104776. PubMed ID: 32736978
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Advances in understanding the functions of native GlyT1 and GlyT2 neuronal glycine transporters" [Neurochem. Int. 99 (2016) 169-77].
Romei C; Raiteri L
Neurochem Int; 2017 Jan; 102():123. PubMed ID: 28057207
[No Abstract] [Full Text] [Related]
12. Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials.
Lichtenstein GR; Diamond RH; Wagner CL; Fasanmade AA; Olson AD; Marano CW; Johanns J; Lang Y; Sandborn WJ
Aliment Pharmacol Ther; 2009 Aug; 30(3):210-26. PubMed ID: 19392858
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and metformin counteract cognitive dysfunction equally in male rats with doxorubicin-induced chemobrain.
Chunchai T; Pintana H; Arinno A; Ongnok B; Pantiya P; Khuanjing T; Prathumsap N; Maneechote C; Chattipakorn N; Chattipakorn SC
Neurotoxicology; 2023 Jan; 94():158-171. PubMed ID: 36463981
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum to "Phragmunis a suppresses glioblastoma through the regulation of MCL1-FBXW7 by blocking ELK1-SRF complex-dependent transcription" [Neurochem. Int. 147 (2021) 105051].
Huang GD; Cui P; Ma GX; Chen FF; Chen ZB; Li XJ; Liao ZJ; Li WP; Li ZY; Chen L
Neurochem Int; 2021 Sep; 148():105106. PubMed ID: 34175129
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Neuromuscular synapse degeneration without muscle function loss in the diaphragm of a murine model for Huntington's Disease" [Neurochem. Int. 116 (2018) 30-42].
Valadão PAC; Gomes MPSM; Aragão BC; Rodrigues HA; Andrade JN; Garcias R; Joviano-Santos JV; Luiz MA; Camargo WL; Naves LA; Kushmerick C; Cavalcante WLG; Gallacci M; de Jesus ICG; Guatimosim S; Guatimosim C
Neurochem Int; 2018 Sep; 118():264. PubMed ID: 29803294
[No Abstract] [Full Text] [Related]
16. Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain.
El-Agamy SE; Abdel-Aziz AK; Esmat A; Azab SS
Cancer Chemother Pharmacol; 2019 Jul; 84(1):1-14. PubMed ID: 30955080
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum to "Neuroprotective role of Ginkgo biloba against cognitive deficits associated with bisphenol A exposure: An animal model study" [Neurochem. Int. 108 (2017) 199-212].
El Tabaa MM; Sokkar SS; Ramadan ES; El Salam IZA; Zaid A
Neurochem Int; 2018 Jun; 116():112. PubMed ID: 29153279
[No Abstract] [Full Text] [Related]
18. Corrigendum to "TLR4-mediated hippocampal MMP/TIMP imbalance contributes to the aggravation of perioperative neurocognitive disorder in db/db mice" [Neurochem. Int. 140 (2020) 104818].
Zhang Y; Liu H; Chen Z; Yu M; Li J; Dong H; Li N; Ding X; Ge Y; Liu C; Ma T; Gui B
Neurochem Int; 2021 Mar; 144():104887. PubMed ID: 33199070
[No Abstract] [Full Text] [Related]
19. Sodium valproate enhances doxorubicin-induced cognitive dysfunction in Wistar rats.
Verma T; Mallik SB; Ramalingayya GV; Nayak PG; Kishore A; Pai KSR; Nandakumar K
Biomed Pharmacother; 2017 Dec; 96():736-741. PubMed ID: 29049976
[TBL] [Abstract][Full Text] [Related]
20. Withdrawal of immunomodulators after co-treatment does not reduce trough level of infliximab in patients with Crohn's disease.
Drobne D; Bossuyt P; Breynaert C; Cattaert T; Vande Casteele N; Compernolle G; Jürgens M; Ferrante M; Ballet V; Wollants WJ; Cleynen I; Van Steen K; Gils A; Rutgeerts P; Vermeire S; Van Assche G
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):514-521.e4. PubMed ID: 25066841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
